Request for Proposals for Case CCC Funding for Pilot/Phase I Clinical Trials
The Case CCC is encouraging investigators to submit Letters of Intent (LOI) for Early Phase Clinical Research Support (EPCRS) funding. These in-house funds are available for the conduct of early phase clinical trials of relatively short duration. Priority will be given to trials which are developed jointly between UH and CCF with planned accrual at both institutions.
The proposals are being accepted on a rolling basis subject to availability of funds.
Please direct any questions and/or submit LOIs to Katarzyna Karelus, Case CCC Clinical Research Office, firstname.lastname@example.org, 216.844.4176.
Pancreatic Cancer Action Network - NCI, Frederick National Laboratory for Cancer Research KRAS Travel Scholarship
The Pancreatic Cancer Action Network and NCI Frederick National Laboratory for Cancer Research (FNLCR) have joined together to award KRAS Travel Scholarships to support travel to FNLCR to pursue cutting edge research on pancreatic cancer and KRAS that is aligned with the RAS Initiative. This is a unique and exciting opportunity for researchers to access the intellectual resources and state-of-the-art technology that are available at FNLCR, the only federal national laboratory in the United States devoted exclusively to biomedical research. A total of $25,000 will be awarded in Travel Scholarships on a rolling basis until these funds are committed. The amount of support requested for travel should be consistent with the time needed to accomplish the proposed scope of work at FNLCR. The Scholarship provides reimbursement directly to the Scholar for reasonable and customary travel expenses to and from FNLCR. Expenses eligible for reimbursement include air and ground transportation, parking, hotel and meals.
Limited Submission Opportunities for Pilot Projects in Non-AIDS Defining Cancers
Deadline: February 27, 2017
With support from a supplement to its NCI P30 grant, the Case Comprehensive Cancer Center in coordination with the CWRU/UH Center for AIDS Research (CFAR) is providing seed funding for the development of cancer research projects focusing on the interface between aging and HIV infection in Non-AIDS Defining Cancers (NADC). The goal of this RFA is to build collaborative projects in cancer biology, aging, immunology, HIV/AIDS, systems biology/informatics, geriatric oncology, geriatric epidemiology, and/or cancer survivorship that will be competitive for nationally-funded multi-PI awards.
An information session will be held in September (date pending) to discuss the goals of the pilot program, facilitate building of NADC teams, describe funding criteria, and outline plans for future grant applications. All teams planning to submit a project should attend.
- Funding for research teams with a focus on unique aspects of aging and NADC in HIV-positive patients
- FOUR research projects will be awarded over two rounds of funding
- Each research project will be funded at a level up to $50,000 for one year.
Ohio Cancer Research
Deadline: Feb 27, 2017
Ohio Cancer Research (OCR) is accepting applications for its 2017 grant competition. The grants awarded will support research activities broadly related to cancer and leukemia. The organization seeks to fund research that will lead to continued support at the national level. The number of grants awarded will depend upon available funds.
OCR targets its grants to junior faculty. Full professors are not eligible to apply and applicants must be independent and within six years of their first independent research position.
Case-Coulter Translational Research Partnership (CCTRP)
Pre-Proposal Deadline: Mar 1, 2017
This is the second year of the third phase of the Case-Coulter Translational Research Partnership (CCTRP) to support collaborative translational research projects that address unmet or poorly met clinical needs. The CCTRP seeks to reduce the market risk of promising new clinical products arising from the research programs of BME and other Case faculty. Successful projects will thus often focus on the development of prototype products, building relationships with companies, performing clinical feasibility studies, obtaining regulatory approval, and other activities that companies or business experts indicate are the essential last steps before a license can be negotiated or a startup launched. An overarching goal of the program is to foster research and development work likely leading to commercially relevant translational technologies within a three- to five-year horizon. Because the goals of all Coulter projects are to reduce market risk, all proposals are expected to reflect genuine business input, and all projects must include a "business advisor" as an important member of the decision making team.
The funding provided by the CCTRP should be considered as a "cooperative agreement" rather than a "grant". That is, the CCTRP staff, Technology Transfer Office (TTO) staff, and the Oversight Committee (OC) are partners in the project rather than a funding agency. Faculty should (and will be expected to) take advantage of the unique resources provided by the program and to include program staff in all major decisions. Project PI's are expected to provide at least monthly updates on progress towards milestones, and timely quarterly reporting from the BME PI of each project will be a milestone of ALL projects and will factor into decisions about continued funding.
Robert Wood Johnson Foundation
Collaborative Pilot Funding Awards
Deadline: Mar 17, 2017
Collaborative pilot funding opportunities are available at the Indiana University Melvin and Bren Simon Cancer Center in Indianapolis.
Made possible by the generosity of the Vera Bradley Foundation for Breast Cancer and the IU Simon Cancer Center, two pilot funding opportunities are available for awards up to $100,000 each to support investigators in collaboration of new breast cancer research partnerships and in collaborative research using the resources (tissue and annotation) from the Komen Tissue Bank at the IU Simon Cancer Center.
Email email@example.com for instructions.
2017 PCF Young Investigator Awards Request for Applications
Deadline: Mar 13, 2017
The Prostate Cancer Foundation (PCF) is pleased to announce a request for applications for Young Investigator Awards. PCF Young Investigator Awards will be three (3) years in duration and will provide $75,000 per year. The award funds, which cover direct costs only, may be used flexibly to advance the career and research efforts of the awardee. Every PCF Young Investigator is required to be under the direct supervision of a mentor. Applicants should be within six-years following completion of a professional degree or clinical training such as MD, PhD, MD-PhD, DSc, ScD, DDM, DDS, DMD, MBBS or equivalent and hold the title of Postdoctoral Fellow, Instructor, Research Associate, Assistant Professor, or equivalent. Applicants should have received no more than $200,000 in current direct research funding from all sources including institutional funds. Investigators who have specifically received young investigator research support from the NCI, NIH, or DoD are still qualified and very much encouraged to apply. Young Investigator awardees are required to attend the Annual PCF Scientific Retreat and Young Investigator Day, typically held in October, throughout the duration of their award and beyond.
Robert Wood Johnson Foundation
Cancer Center Summer Training for Medical Students
Deadline: Mar 31, 2017
The Case Comprehensive Cancer Center is looking for medical students interested in summer research opportunities. There are 9 openings available, with 5 supported by the Brian Werbel Memorial Fund and 4 by the Case Comprehensive Cancer Center.
Completed application and reference letter due by: Friday, March 31, 2017
Awardees must be conducting cancer research with a Case Comprehensive Cancer Center member. View list of members.
Those receiving the Brian Werbel Memorial Fund awards must attend the annual golf outing.
Contact Damian Junk at firstname.lastname@example.org with any questions.
Prostate Cancer Foundation
Deadline: Apr 24, 2017
The Prostate Cancer Foundation (PCF) is pleased to announce a Request for Applications for PCF Challenge Awards for investigations of metastatic, lethal prostate cancer. These awards will be funded depending on the level of innovation in applications received. High risk, currently unfunded projects are most desired.
Team science awards are composed of at least three (3) investigators from non-profit academic research centers, including one young investigator (see RFA for PCF Challenge Award Team requirements).
Support large-scale research projects concerning metastatic, lethal prostate cancer over a duration of two years.
Provide up to a total of $1 million per team.
Cover only direct research costs and travel to the Annual PCF Scientific Retreat.
Limited Submission: W.M. Keck Foundation
Shared Instrumentation Grant (SIG) Program (S10)
Types of supported instruments include, but are not limited to: X-ray diffractometers, mass and nuclear magnetic resonance (NMR) spectrometers, DNA and protein sequencers, biosensors, electron and light microscopes, cell sorters, and biomedical. Applications for "stand alone" computer systems (supercomputers, computer and data storage systems) will only be considered if the instrument is solely dedicated to the research needs of NIH-supported investigators.
Open Funding Opportunities
Limited Submission: V Foundation for Cancer Research 2017 Translational Research Award
Deadline: Feb 24, 2017
The Case Comprehensive Cancer Center is invited to submit TWO nominees for consideration for the V Foundation Translational Award, if at least one of the two nominee applicants is submitting a research project that focuses on the biological basis of cancer disparities experienced by patients from minority ethnic or racial populations in cancer causes, aggressiveness, treatment or relapse. Minorities for the purposes of this application are defined as African Americans or people of African descent, Pacific Islanders, Hispanic Americans and Native Americans and Alaskan Natives.
As in previous years, any area of cancer research is permitted. However, research on cancers that are more prevalent or aggressive in specific ethnic populations is encouraged, but not required. Cancers in which ethnic and racial disparities have previously been shown include: lung and bronchus, colon and rectum, breast, prostate, uterine, cervix, stomach and liver. As in 2016, among the highly ranked finalists for the 2017 Translational Award program, the V Foundation will designate at least one of the highest ranked applications as the recipient of a Stuart Scott Memorial Fund Translational Research Award. While not required, the Foundations has a special interest in supporting immune oncology and immunotherapy research, when applicable.
To be considered for the nomination, submit a one-page LOI and biosketch to Kristin Waite (email@example.com) by Friday, February 24, 2017.
Deadline: Mar 1, 2017
This request for proposals (RFP) is offered by the When Everyone Survives Foundation (WES Foundation) to solicit innovative research in leukemia. Grants of $50,000 for one year are offered to new and established investigators who are requesting support for laboratory, translational, or clinical research related to acute leukemia. The WES Foundation is supporting leukemia research because it recognizes that significant advances in the understanding, diagnosis, and treatment of leukemia are needed to achieve the goal of "when everyone survives". Renewal of initial research support may be considered for one or more additional years based upon productivity.
SWOG/Hope Foundation Impact Award
Deadline: Mar 1, 2017
The SWOG/Hope Foundation Impact Award is a funding program that encourages novel and innovative SWOG research by supporting early and conceptual stages of these projects.
The work proposed should use resources from completed SWOG trials or be directly translatable to future clinical trials in SWOG and the National Clinical Trials Network ( NCTN). These studies may involve scientific risk but potentially lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on cancer research.
It is expected that support via this mechanism will lead to subsequent extramural support from other sources, and will be a metric of success for this grant program. In addition, publications citing SWOG and The Hope Foundation will be further metrics for success.
Request for Applications: Opportunities for Pilot Projects from VeloSano Bike to
Deadline: Mar 6, 2017
With the generous support from VeloSano Bike to Cure 2016, the Case Comprehensive Cancer Center is providing seed funding for the initiation of novel projects aligned with at least one of the seven Research Programs (GI Cancer Genetics, Molecular Oncology, GU Malignancies, Hematopoietic and Immune Cancer Biology, Developmental Therapeutics, Cancer Imaging, or Cancer Prevention, Control, & Population Research) or the Brain Tumor or Breast Cancer research initiatives within the Center. Highly innovative and impactful proposals are sought that will generate key data for larger, nationally competitive grants that interface with the Strategic Plan of the aligned program(s). Proposals must include collaborative, multi-investigator projects. In addition, projects that focus on renal cancer biology, disparities research, brain tumors, or drug discovery and screening are particularly encouraged.
Eligibility for funds will be restricted to lead PIs that are Center members who participated in VeloSano Bike to Cure 2016 (rider, virtual rider, or volunteer). In addition, the lead PI of the application must not be eligible for CCF VeloSano funding. Co-PIs and Co-investigators are not required to have been VeloSano participants. All awardees (PIs and co-investigators) will be expected to participate in VeloSano 2017 as well as to present their research progress when requested by the Case Comprehensive Cancer Center.
UH Harrington Scholar-Innovator Program
LOI Deadline: Apr 5, 2017
Invited Application Deadline: May 31, 2017
The Harrington Scholar-Innovator Award recognizes physician-scientist innovators throughout the U.S. whose research has the potential to change standard of care. The Scholar-Innovator Award provides research and drug development support to help bridge the gap between basic discovery and the clinic.
Up to 12 Harrington Scholar-Innovator awards will be made each year through a competitive selection process. Awardees are selected by the Harrington Discovery Institute's Scientific Advisory Board.
Dr. Alma S. Adams Scholarship for Outreach and Health Communications to Reduce Tobacco Use Among Priority Populations
Deadline: Apr 30, 2017
Putting an end to tobacco use depends on young people who are eager to help achieve a tobacco-free generation. That's why Truth Initiative® is offering two $5,000 scholarships to support undergraduate and graduate students who are innovatively confronting tobacco use.
Over the past decade, the Dr. Alma S. Adams Scholarship for Outreach and Health Communications to Reduce Tobacco Use Among Priority Populations has recognized students for their commitment to community service and use of the creative arts to raise awareness of tobacco's harmful impacts in disproportionately affected communities.
This year's scholarship will be awarded based on creative community service that reflects four major tobacco-control related issues: smoke-free environments, social justice, tobacco product flavors and point-of-sale ( where tobacco products are sold ).
Alex's Lemonade Stand Foundation Pediatric Oncology Student Training Program
Deadline: May 1, 2017
Alex's Lemonade Stand Foundation (ALSF) is dedicated to funding pediatric oncology researchers at critical points in their careers. The Pediatric Oncology Student Training (POST) Program is designed for undergraduate, graduate and medical students who have an interest in pediatric oncology research and would like to experience the field first hand by working on a mentored research project during a school break (typically summer). Students train with a pediatric oncology research mentor who is an ALSF grantee, Advisory Board member, or Review Board member. Students may join a research project underway in a mentor's lab or begin an original investigation with the mentor.